Rebecca Clegg Image

Rebecca Clegg

Counsel

Axinn, Veltrop & Harkrider

Rebecca Clegg is Counsel at Axinn, Veltrop & Harkrider LLP, where her practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits. She also has experience representing clients in commercial litigation cases.

Rebecca received her law degree from the University of Connecticut School of Law, which she attended on a full-tuition merit scholarship. While at UConn Law, she served as Competition Editor for the Connecticut Law Review, worked in the Intellectual Property and Entrepreneurship Law Clinic, and earned multiple CALI Excellence for the Future Awards. Rebecca was a summer associate with Axinn in 2014. She graduated magna cum laude from Mount Holyoke College in 2012 with a degree in History and Physics.

Recent Articles by Rebecca Clegg

The CRISPR Tug of War

The University of California (“UC”) and The Broad Institute, Inc. (“Broad”) are among the leaders in the development of CRISPR technology.  Both UC and Broad filed patent applications for claims broadly drawn to CRISPR-Cas9 systems and methods of DNA editing.  These parties are currently engaged in litigation over patents concerning the potentially most lucrative application of CRISPR technology – the use of CRISPR-Cas9 in plant and animal (eukaryotic) cells.  The outcome of this litigation will affect control of the CRISPR platform and development of the technology.